2rounds
—led
Enterprise software 1Fintech 1
Series A 1, Series C+ 1
Loading investors…
Loading investors…
Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 4, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series A 2
Caplight Technologies $16M Series AOutmarket AI $17M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Taktile $110M Series CTower €5.5M Pre-Seed+SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Anodyne Nanotech $12.6M Series ACo-Reactive €6.5M SeedNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
xCures $46M Series BSewerAI Undisclosed StrategicNew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Stegra €1.4B GrowthAfresh $34M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
RQ Bio $115M Series AExciva €51M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Platformr $10M UndisclosedArpio $15M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
JUPUS €13M Series AConvelio Undisclosed Series CNew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Ubotica Technologies $11M UndisclosedGridBeyond €12M GrowthNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Ladder Health $7M SeedHLRBO $2.5M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
TRIMTECH Therapeutics $47M Seed+Semarion $3.8M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Peregrine Technologies $250M Series DVital Signals $15M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Bionyra Pharma $165M Series ACrossbow Therapeutics $77M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Graph Therapeutics $5M Series AAnother Earth €3.5M SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Graph Therapeutics $5M Series AAnother Earth €3.5M Seed“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.